Novonix (NASDAQ: NVX) completes A$962,600 Share Purchase Plan issue

Rhea-AI Filing Summary

NOVONIX Limited completed a Share Purchase Plan, issuing 6,016,250 fully paid ordinary shares at A$0.16 each to raise A$962,600 before costs. The offer, which closed on 17 July 2026, allowed eligible shareholders to apply for up to A$30,000 of new shares.

The company plans to use the proceeds to fund capital expenditure to support production capacity and forecast customer demand. Valid applications were received from approximately 89 eligible shareholders, with an average application of approximately A$10,816 and a participation rate of approximately 0.3% of eligible shareholders.

The 6,016,250 new SPP Shares represent approximately 0.6% of NOVONIX’s ordinary shares on issue. Following quotation, total ordinary fully paid shares quoted on ASX are 997,612,994.

Filing Explained

No further SPP issue remains, but 45,221,586 convertible notes and 35,000,000 convertible debentures remain unquoted.

This Form 6-K records an ASX application to quote the SPP shares, with an issue date of July 22, 2026; the filing does not confirm that ASX trading has begun.

It says no further issue is required to complete the transaction. After quotation, quoted ordinary shares would total 997,612,994, while the unquoted capital also includes 21,565,395 performance rights, 14,016,667 options, 1,371,566 share rights, 45,221,586 convertible notes, and 35,000,000 convertible debentures.

The disclosure therefore distinguishes the SPP’s issue and quotation step from the company’s other securities that remain issued but unquoted.

Key Figures

SPP shares issued: 6,016,250 shares SPP gross proceeds: A$962,600 SPP issue price: A$0.16 per share +5 more

8 metrics

SPP shares issued 6,016,250 shares New SPP Shares issued on 22 July 2026

SPP gross proceeds A$962,600 Capital raised before costs under the Share Purchase Plan

SPP issue price A$0.16 per share Price per SPP Share, equal to Institutional Placement price

Maximum SPP application A$30,000 Maximum amount eligible shareholders could apply for in SPP Shares

Participating shareholders approximately 89 Eligible shareholders submitting valid SPP applications

Participation rate approximately 0.3% Share of eligible shareholders participating in the SPP

Dilution from SPP approximately 0.6% New SPP Shares as a percentage of ordinary shares on issue

Total ordinary shares 997,612,994 shares Ordinary fully paid shares quoted on ASX after SPP quotation

Key Terms

Share Purchase Plan, Institutional Placement, Appendix 2A, performance rights, +1 more

5 terms

Share Purchase Plan financial

"NOVONIX received valid applications from eligible shareholders for 6,016,250 fully paid ordinary shares in NOVONIX ("SPP Shares") to raise A$962,600 (before costs) under the SPP."

A share purchase plan is an offer that lets existing shareholders buy additional shares directly from a company, usually at a set price and often with lower fees than buying on the open market. Think of it like a limited-time group sale that raises cash for the company; it matters to investors because it can be a cheap way to increase holdings, but adding more shares can reduce each existing share's slice of ownership and influence the stock price.

Institutional Placement financial

"The SPP was announced on 17 June 2026, in connection with a fully underwritten institutional placement of A$20.7 million to sophisticated investors ("Institutional Placement")."

Appendix 2A regulatory

"We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules."

performance rights financial

"NVXAD PERFORMANCE RIGHTS | 21,565,395"

Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.

convertible debentures financial

"NVXAH CONVERTIBLE DEBENTURES | 35,000,000"

Convertible debentures are loans a company issues that pay interest like a bond but can be swapped later for the company’s shares at a set price. For investors they act like a safety-net plus a shortcut: you get regular interest payments while retaining the option to join ownership if the share price rises, which offers upside potential but can dilute existing shareholders if conversion occurs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/22/2026 - 06:02 AM Accepted by SEC EDGAR 07/21/2026 - 07:44 PM Learn about SEC filing dates

FAQ

How much capital did NOVONIX (NVX) raise in the July 2026 Share Purchase Plan?

NOVONIX raised A$962,600 before costs through its July 2026 Share Purchase Plan. This came from valid applications for 6,016,250 new shares at A$0.16 each from eligible shareholders.

What was the issue price and share volume for NOVONIX (NVX) SPP shares?

NOVONIX issued 6,016,250 fully paid ordinary shares at an issue price of A$0.16 per share. These new SPP Shares are expected to commence trading on ASX on 23 July 2026.

How dilutive was the NOVONIX (NVX) Share Purchase Plan to existing shareholders?

The Share Purchase Plan resulted in 6,016,250 new shares, representing approximately 0.6% of NOVONIX’s ordinary shares on issue. After quotation, total ordinary fully paid shares on ASX are 997,612,994.

What will NOVONIX (NVX) use the Share Purchase Plan proceeds for?

NOVONIX intends to use the A$962,600 raised under the Share Purchase Plan to fund capital expenditure required to support production capacity and meet forecast customer demand for its battery materials.

How many NOVONIX (NVX) shareholders participated in the July 2026 SPP?

Approximately 89 eligible shareholders submitted valid applications under the Share Purchase Plan. This equated to a participation rate of approximately 0.3% of eligible shareholders and an average application size of about A$10,816.

What is NOVONIX (NVX)’s total issued share capital after the SPP shares are quoted?

Following quotation of the 6,016,250 SPP Shares, NOVONIX will have 997,612,994 ordinary fully paid shares quoted on ASX. The company also has several classes of unquoted securities, including performance rights and convertible instruments.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of July, 2026

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		Results of Share Purchase Plan Offer dated July 21, 2026
Exhibit 99.2		Appendix 2A (Application for quotation of securities) dated July 21, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:	/s/ Mike O'Kronley
	Mike O'Kronley
	Chief Executive Officer

Date: July 22, 2026

Exhibit 99.1

Asx Announcement

(ASX: NVX)

NOT FOR RELEASE TO US WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES

Results of Share Purchase Plan Offer

BRISBANE, AUSTRALIA, July 21, 2026 - NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, advises that the Share Purchase Plan (SPP) closed at 5:00pm on 17 July 2026.

NOVONIX received valid applications from eligible shareholders for 6,016,250 fully paid ordinary shares in NOVONIX ("SPP Shares") to raise A$962,600 (before costs) under the SPP.

The SPP was priced at A$0.16 per SPP Share, and eligible shareholders were given the opportunity to apply for up to A$30,000 worth of SPP Shares.

NOVONIX will use the proceeds from the SPP to fund capital expenditure required to support production capacity and meet forecast customer demand.

Admiral Robert Natter, NOVONIX Chairman said: “We were pleased to provide all of our eligible shareholders with the opportunity to participate in this offer. We received strong interest in the offer. We thank our shareholders for their ongoing support of NOVONIX and its future.”

SPP Further Details

The SPP was announced on 17 June 2026, in connection with a fully underwritten institutional placement of A$20.7 million to sophisticated investors ("Institutional Placement"). NOVONIX successfully completed the Institutional Placement on 17 June 2026.

The issue price of A$0.16 per SPP Share is equivalent to the issue price paid by investors under the Institutional Placement and Conditional Placement launched by NOVONIX in conjunction with the SPP.

ACN 157 690 830, 1029 West 19th Street; Chattanooga, TN 37408; USA | novonixgroup.com

Exhibit 99.1

The SPP offer was made to eligible shareholders, with valid applications received from approximately 89 eligible shareholders for a total value of A$962,600. Valid applications received represented a participation rate of approximately 0.3% of eligible shareholders, with an average application amount of approximately A$10,816.

6,016,250 new SPP Shares will be issued on 22 July 2026, representing approximately 0.6% of NOVONIX’s ordinary shares on issue.

Trading of the SPP Shares is expected to commence on the ASX on 23 July 2026. Holding statements will be dispatched to successful applicants from 23 July 2026. SPP Shares will rank equally with existing fully paid NVX shares from their date of issue.

This announcement has been authorised for release by Admiral Robert Natter, Chairman.

About NOVONIX
NOVONIX is building a resilient North American battery materials supply chain to reduce risk and support US energy independence. Headquartered in Chattanooga, Tennessee, the company produces high-performance synthetic graphite anode materials for lithium-ion batteries, serving energy storage, electric vehicle and industrial markets. Through proprietary technologies and expanding manufacturing capacity, NOVONIX is scaling critical battery materials to meet growing global demand.

To learn more, visit us at www.novonixgroup.com or on LinkedIn and X.

For NOVONIX Limited
ir@novonixgroup.com (investors)
media@novonixgroup.com (media)

Forward-looking statements This announcement contains certain "forward-looking statements" that are based on management's beliefs, assumptions, opinions and expectations and on information currently available to management as of the date of this announcement. All statements other than statements of historical facts included in this announcement, including statements regarding NOVONIX’s forecasts, business strategy, plans and objectives, are forward-looking statements. These statements can generally be identified by the use of forward-looking words such as "expect", "anticipate", "likely", "intend", "should", "could", "may", "predict", "plan", "propose", "will", "believe", "forecast", "estimate' or "target". Such

ACN 157 690 830, 1029 West 19th Street; Chattanooga, TN 37408; USA | novonixgroup.com

Exhibit 99.1

statements may be based on underlying assumptions (which could prove incorrect or may be subject to change) and are subject to the risks disclosed in the Company's most recent annual report on Form 20-F, many of which are outside the control of NOVONIX and are not reliably predictable, which could cause actual results to differ materially, in terms of quantum and timing, from any results described in this announcement. You are strongly cautioned not to place undue reliance on forward-looking statements. Copies of the Company’s most recent annual report may be obtained by visiting the Company’s Investor Relations website at www.novonixgroup.com or the SEC’s website at www.sec.gov. No representation is made by NOVONIX or Bell Potter Securities Limited ("Lead Manager") or any of their respective related bodies corporate, shareholders or affiliates, or any of each of their respective officers, directors, partners, employees, consultants, contractors, affiliates, agents, advisers or representatives (each a “Limited Party” and together, the “Limited Parties”) as to the correctness of the forward-looking statements on or after the date of this announcement. NOVONIX does not undertake any obligation to publicly release the result of any revisions to these forward-looking statements to reflect events or circumstances after the date of this announcement or to reflect the occurrence of unanticipated events. To the maximum extent permitted by law, NOVONIX, the Lead Manager and each of their respective Limited Parties disclaim any responsibility for the accuracy or completeness of any forward-looking statements whether as a result of new information, future events or results or otherwise. To the maximum extent permitted by law, each of NOVONIX, the Lead Manager and each of their respective Limited Parties disclaim any responsibility to update or revise any forward-looking statement to reflect any change in NOVONIX's financial condition, status or affairs or any change in the events, conditions or circumstances on which a statement is based, except as required by Australian law.

Not for distribution or release in the United States
This announcement has been prepared for publication in Australia and may not be released or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. Any securities described in this announcement have not been, and will not be, registered under the US Securities Act of 1933 and may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the US Securities Act and applicable US state securities laws.

ACN 157 690 830, 1029 West 19th Street; Chattanooga, TN 37408; USA | novonixgroup.com

Exhibit 99.2

Announcement Summary

Entity name

NOVONIX LIMITED

Announcement Type

New announcement

Date of this announcement

Tuesday July 21, 2026

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Total number of +securities to be quoted

	ASX +security code	Security description	Number of +securities to be quoted Issue date
	NVX	ORDINARY FULLY PAID	6,016,250 22/07/2026

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

1.1 Name of entity

NOVONIX LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type	Registration number
ABN	54157690830

1.3 ASX issuer code

NVX

1.4 The announcement is

New announcement

1.5 Date of this announcement

21/7/2026

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Previous Appendix 3B details:

Announcement Date and Time	Announcement Title	Selected Appendix 3B to submit quotation request
17-Jun-2026 10:03	New - Proposed issue of securities - NVX	An offer of +securities under a +securities purchase plan

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

No

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Corporate Action Component Detail

ASX +security code and description

NVX : ORDINARY FULLY PAID

Issue date

22/7/2026

Issue details

Number of +securities to be quoted

6,016,250

Are the +securities being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid?	What is the issue price per +security?
AUD - Australian Dollar	AUD 0.16000000

Any other information the entity wishes to provide about the +securities to be quoted

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the

+securities subject of this application)

ASX +security code and description	Total number of +securities on issue
NVX : ORDINARY FULLY PAID	997,612,994

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

ASX +security code and description	Total number of +securities on issue
NVXAD : PERFORMANCE RIGHTS	21,565,395
NVXAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	14,016,667
NVXAM : SHARE RIGHTS	1,371,566
NVXAL : CONVERTIBLE NOTES	45,221,586
NVXAH : CONVERTIBLE DEBENTURES	35,000,000

Filing Exhibits & Attachments

2 documents

Press Releases

• EX-99.1 EX-99.1 29.8 KB
• EX-99.2 EX-99.2 55.0 KB